Graeme Freestone
8Patents
2h-index
16Co-inventors
40Inventor score
Filing activity: Oct 11, 2011 → Nov 25, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9932345B2 | Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors | Chemistry; Metallurgy | 3 | Active |
| US9150572B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9102674B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9675605B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11186582B2 | Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9012470B2 | Therapeutic 5,6,5-tricyclic analogs | Chemistry; Metallurgy | 0 | Active |
| US10501465B2 | Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9956213B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.